Proteomic analysis of protein changes in plasma by balloon test occlusion.

Area of Science:

• Neuroscience
• Biochemistry
• Proteomics

Background:

• Transient ischemia confers tolerance against prolonged ischemic events in the brain.
• Animal models show transient ischemia alters circulating proteins linked to neuroprotection, but human data is limited.

Purpose of the Study:

• To investigate changes in human plasma protein composition following transient cerebral ischemia.
• To identify specific proteins altered by balloon test occlusion (BTO) that may indicate neuroprotective mechanisms.

Main Methods:

• Blood samples were collected from nine patients before and 48 hours after BTO.
• Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used for proteomic analysis to quantify protein levels.

Main Results:

• Leucine-rich alpha-2-glycoprotein and serum amyloid A-1 levels significantly increased post-BTO.
• Protein AMBP levels decreased in plasma samples after BTO.
• Transient alteration of cerebral blood flow impacts plasma molecular expression.

Conclusions:

• The study demonstrates that transient cerebral ischemia alters plasma protein profiles in humans.
• Proteins identified as changing post-BTO, such as leucine-rich alpha-2-glycoprotein and serum amyloid A-1, may play a role in human ischemic tolerance and neuroprotection.